Results show, for the first time, that targeting underlying a-syn pathology with an active immunotherapy could slow the rate of progression of Parkinson’s disease Clear safety profile with no ...
AC Immune Positive Interim Phase 2 Data on ACI-7104.056 Support Potential Slowing of Progression of Parkinson’s Disease Results show, for the first time, that targeting underlying a-syn pathology with ...
Lausanne, Switzerland, December 11, 2025 -- AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision therapeutics for neurodegenerative diseases, today announced ...
Protection Coordination in AC Microgrid via Novel Voltage-Supervised Directional Over-Current Relays
Abstract: Conventional protection schemes are susceptible to dynamic changes in AC microgrids having diverse Distributed Generators (DGs). These changes, caused by different DG types, significantly ...
Researchers from the University of Birmingham have received approximately £1.1M funding from the Gates Foundation to establish a specialised team that will assess new non-hormonal contraceptives, ...
Abstract: The novel inverter topologies are often intriguing and ignite interest in knowing the rationale behind their circuit synthesis, which is usually not detailed. This article provides a step-by ...
A new national report has shown for the first time how generative AI (GenAI) is already being used by some universities to assess the quality of their research – and it could be scaled up to help all ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback